149 related articles for article (PubMed ID: 18991236)
1. [Topiramate augmentation in treatment-resistant obsessive-compulsive disorder].
Vinkers DJ; van der Wee NJ
Tijdschr Psychiatr; 2008; 50(11):747-50. PubMed ID: 18991236
[TBL] [Abstract][Full Text] [Related]
2. Topiramate plus paroxetine in treatment-resistant obsessive-compulsive disorder.
Hollander E; Dell'Osso B
Int Clin Psychopharmacol; 2006 May; 21(3):189-91. PubMed ID: 16528143
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.
Berlin HA; Koran LM; Jenike MA; Shapira NA; Chaplin W; Pallanti S; Hollander E
J Clin Psychiatry; 2011 May; 72(5):716-21. PubMed ID: 20816027
[TBL] [Abstract][Full Text] [Related]
4. Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series.
Van Ameringen M; Mancini C; Patterson B; Bennett M
Depress Anxiety; 2006; 23(1):1-5. PubMed ID: 16178009
[TBL] [Abstract][Full Text] [Related]
5. The effect of riluzole augmentation in a patient with treatment-resistant obsessive-compulsive disorder, taking two other glutaminergic agents.
Mahgoub N; Asemota B; Alexopoulos GS
J Neuropsychiatry Clin Neurosci; 2011; 23(2):E24-5. PubMed ID: 21677213
[No Abstract] [Full Text] [Related]
6. Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.
Häge A; Banaschewski T; Buitelaar JK; Dijkhuizen RM; Franke B; Lythgoe DJ; Mechler K; Williams SC; Dittmann RW;
Trials; 2016 Mar; 17(1):141. PubMed ID: 26983548
[TBL] [Abstract][Full Text] [Related]
7. Topiramate related obsessive-compulsive disorder.
Ozkara C; Ozmen M; Erdogan A; Yalug I
Eur Psychiatry; 2005 Jan; 20(1):78-9. PubMed ID: 15642451
[No Abstract] [Full Text] [Related]
8. Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial.
Sahraian A; Bigdeli M; Ghanizadeh A; Akhondzadeh S
J Affect Disord; 2014 Sep; 166():201-5. PubMed ID: 25012432
[TBL] [Abstract][Full Text] [Related]
9. Topiramate augmentation in a patient with obsessive-compulsive disorder.
Van Ameringen M; Patterson B
J Psychiatry Neurosci; 2015 Sep; 40(5):E31-2. PubMed ID: 26290064
[No Abstract] [Full Text] [Related]
10. Compulsive buying treatment with topiramate, a case report.
Guzman CS; Filomensky T; Tavares H
Braz J Psychiatry; 2007 Dec; 29(4):383-4. PubMed ID: 18200404
[No Abstract] [Full Text] [Related]
11. The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder.
Rubio G; Jiménez-Arriero MA; Martínez-Gras I; Manzanares J; Palomo T
J Clin Psychopharmacol; 2006 Jun; 26(3):341-4. PubMed ID: 16702907
[No Abstract] [Full Text] [Related]
12. Compulsive skin manipulation treated by topiramate.
Ye L; Bawa R; Lippmann S
J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):369-70. PubMed ID: 23782131
[No Abstract] [Full Text] [Related]
13. Topiramate-induced psychosis.
Kober D; Gabbard GO
Am J Psychiatry; 2005 Aug; 162(8):1542. PubMed ID: 16055782
[No Abstract] [Full Text] [Related]
14. Lamotrigine as an augmentation agent in treatment-resistant obsessive-compulsive disorder: a case report.
Uzun O
J Psychopharmacol; 2010 Mar; 24(3):425-7. PubMed ID: 19010977
[TBL] [Abstract][Full Text] [Related]
15. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.
Pittenger C; Krystal JH; Coric V
NeuroRx; 2006 Jan; 3(1):69-81. PubMed ID: 16490414
[TBL] [Abstract][Full Text] [Related]
16. Topiramate and compulsive buying disorder.
Ye L; Kadia S; Lippmann S
J Clin Psychopharmacol; 2014 Feb; 34(1):174-5. PubMed ID: 24346750
[No Abstract] [Full Text] [Related]
17. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.
Coric V; Taskiran S; Pittenger C; Wasylink S; Mathalon DH; Valentine G; Saksa J; Wu YT; Gueorguieva R; Sanacora G; Malison RT; Krystal JH
Biol Psychiatry; 2005 Sep; 58(5):424-8. PubMed ID: 15993857
[TBL] [Abstract][Full Text] [Related]
18. Memantine augmentation for refractory obsessive-compulsive disorder.
Pasquini M; Biondi M
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1173-5. PubMed ID: 16730870
[TBL] [Abstract][Full Text] [Related]
19. Potential role of anticonvulsants in the treatment of obsessive-compulsive and related disorders.
Wang HR; Woo YS; Bahk WM
Psychiatry Clin Neurosci; 2014 Oct; 68(10):723-32. PubMed ID: 24735021
[TBL] [Abstract][Full Text] [Related]
20. Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.
Feusner JD; Kerwin L; Saxena S; Bystritsky A
Psychopharmacol Bull; 2009; 42(1):81-93. PubMed ID: 19204653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
